Short-term Effect of a New Nordic Renal Diet on Phosphorus Homeostasis in CKD Stage 3-4
1 other identifier
interventional
18
1 country
1
Brief Summary
Hyperphosphatemia is a severe complication to chronic kidney disease (CKD) and is associated with increased risk of vascular calcification, cardiovascular morbidity and mortality. Early dietary intervention and improvement in dietary therapy might optimally reduce cardiovascular complications. For this purpose the investigators investigated patients with CKD stage 3-4, the participants dietary habits, developed a New Nordic Renal Diet and investigated the short term effect on phosphorus homeostasis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 6, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 6, 2017
CompletedFirst Submitted
Initial submission to the registry
March 13, 2018
CompletedFirst Posted
Study publicly available on registry
March 21, 2018
CompletedNovember 13, 2019
November 1, 2019
9 months
March 13, 2018
November 11, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
24-hour urine phosphorus excretion
primary outcome was measured by 24-hour urine collection
7 days
Study Arms (2)
Habitual diet
OTHER18 participants were on a habitual diet for 7 days
New Nordic Renal Diet
ACTIVE COMPARATOR18 participants were given a New Nordic Renal Diet for 7 days
Interventions
One week ingesting a phosphorus reduced diet containing a total of 850 mg of phosphorus/day compared to one week of a habitual diet
Eligibility Criteria
You may qualify if:
- Estimated glomerular filtration rate (eGFR) 16 to 45 ml/min/1.73 m2, as judged by CKD-EPI equation
- Medically stable for 2 months before and during the study
- No food allergies
- Ability to understand the Danish language orally and in writing
You may not qualify if:
- \- Intake of phosphate binders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arne V. Astrup
Copenhagen, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 13, 2018
First Posted
March 21, 2018
Study Start
February 1, 2017
Primary Completion
November 6, 2017
Study Completion
November 6, 2017
Last Updated
November 13, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share